Katharine Knobil

Overview

Katharine Knobil received an average of $2M in total compensation, including $313K in salary, at Kaleido Biosciences from 2018 to 2020.

Source: SEC filings on May 5, 2021 and May 8, 2020.

Related executives

We found five more executives who work or worked at Kaleido Biosciences.

Daniel Menichella

Kaleido Biosciences

Chief Executive Officer

William Duke

Kaleido Biosciences

Chief Financial Officer

Alison Lawton

Kaleido Biosciences

Chief Executive Officer

Jerald Korn

Kaleido Biosciences

General Counsel

Joshua Brumm

Kaleido Biosciences

Chief Financial Officer

News

You may also like